Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Isatuximab SAR650984 for Autoimmune Hemolytic Anemia
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing the safety and effectiveness of isatuximab injections in adults with warm Autoimmune Hemolytic Anemia (wAIHA). The medication works by attaching to immune cells and helping to stop them from destroying red blood cells. The study aims to see if this treatment can reduce symptoms and improve patient outcomes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service